Avenue Therapeutics (ATXI) Institutional Ownership $1.85 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.90 +0.04 (+2.43%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for Avenue Therapeutics (NASDAQ:ATXI)CurrentInstitutional OwnershipPercentage17.34%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$289.89KNumber ofInstitutional Sellers(last 12 months)0 Get ATXI Insider Trade Alerts Want to know when executives and insiders are buying or selling Avenue Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ATXI Institutional Buying and Selling by Quarter Avenue Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/18/2024 Moss Adams Wealth Advisors LLC11,000$27K0.0%N/A1.169% 8/15/2024Armistice Capital LLC75,000$262K0.0%N/A7.970% 1/28/2022National Asset Management Inc.71,338$65K0.0%-20.1%0.376% 11/16/2021National Asset Management Inc.89,237$133K0.0%-29.2%0.531% 10/19/2021Kestra Advisory Services LLC22,500$34K0.0%N/A0.134% 9/17/2021Virtu Financial LLC26,373$66K0.0%N/A0.157% 9/3/2021Parametric Portfolio Associates LLC10,554$26K0.0%-59.2%0.063% 8/16/2021Occudo Quantitative Strategies LP14,398$36K0.0%N/A0.086% 8/13/2021Renaissance Technologies LLC78,314$197K0.0%N/A0.468% 8/13/2021Northern Trust Corp13,767$35K0.0%-82.1%0.082% Get the Latest News and Ratings for ATXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/13/2021Geode Capital Management LLC79,556$199K0.0%-40.0%0.475% 8/13/2021Vanguard Group Inc.449,982$1.13M0.0%-35.5%2.687% 8/12/2021XTX Topco Ltd10,864$27K0.0%N/A0.065% 8/12/2021Advisory Services Network LLC35,121$88K0.0%N/A0.210% 8/12/2021Ergoteles LLC30,400$76K0.0%N/A0.182% 8/10/2021National Asset Management Inc.126,037$317K0.0%-26.1%0.753% 5/20/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060% 5/19/2021Squarepoint Ops LLC11,668$71K0.0%N/A0.070% 5/17/2021Goldman Sachs Group Inc.17,319$105K0.0%N/A0.103% 5/13/2021Trexquant Investment LP13,874$84K0.0%N/A0.083% 5/13/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060% 5/13/2021Barclays PLC5,568$34K0.0%+159.0%0.033% 5/12/2021Northern Trust Corp77,049$467K0.0%-6.8%0.460% 5/12/2021Geode Capital Management LLC132,594$804K0.0%+5.9%0.792% 2/24/2021Virtu Financial LLC17,469$104K0.0%N/A0.104% 2/19/2021JPMorgan Chase & Co.17,102$101K0.0%+260.2%0.102% 2/17/2021Jane Street Group LLC13,288$79K0.0%N/A0.079% 2/11/2021Northern Trust Corp82,691$492K0.0%+2.1%0.494% 2/9/2021Wells Fargo & Company MN16,406$98K0.0%-13.2%0.098% 2/5/2021BlackRock Inc.361,486$2.15M0.0%+5.5%2.158% 2/4/2021National Asset Management Inc.167,787$999K0.1%+15.0%1.002% 11/13/2020Morgan Stanley22,706$246K0.0%+270.9%0.136% (Data available from 1/1/2016 forward) ATXI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ATXI shares? During the previous two years, the following institutional investors and hedge funds held shares of Avenue Therapeutics shares: Armistice Capital LLC ($262K), Moss Adams Wealth Advisors LLC ($27K).Learn more on ATXI's institutional investors. What percentage of Avenue Therapeutics stock is owned by institutional investors? 17.34% of Avenue Therapeutics stock is owned by institutional investors. Learn more on ATXI's institutional investor holdings. Which institutional investors have been buying Avenue Therapeutics stock? The following institutional investors have purchased Avenue Therapeutics stock in the last 24 months: Armistice Capital LLC ($75K), and Moss Adams Wealth Advisors LLC ($11K). How much institutional buying is happening at Avenue Therapeutics? Institutional investors have bought a total of 86,000 shares in the last 24 months. This purchase volume represents approximately $289.89K in transactions. Related Companies Minerva Neurosciences Major Shareholders ProPhase Labs Major Shareholders Cingulate Major Shareholders Spruce Biosciences Major Shareholders NeuroSense Therapeutics Major Shareholders HCW Biologics Major Shareholders Bright Green Major Shareholders Flora Growth Major Shareholders AIM ImmunoTech Major Shareholders Sensei Biotherapeutics Major Shareholders This page (NASDAQ:ATXI) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
